The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 176, S21-S141, 2019 | 804 | 2019 |
G protein–coupled receptor oligomerization revisited: functional and pharmacological perspectives S Ferré, V Casadó, LA Devi, M Filizola, R Jockers, MJ Lohse, G Milligan, ... Pharmacological reviews 66 (2), 413-434, 2014 | 620 | 2014 |
The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 178, S27-S156, 2021 | 503 | 2021 |
Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain E Balland, J Dam, F Langlet, E Caron, S Steculorum, A Messina, S Rasika, ... Cell metabolism 19 (2), 293-301, 2014 | 494 | 2014 |
Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release Y Suofu, W Li, FG Jean-Alphonse, J Jia, NK Khattar, J Li, SV Baranov, ... Proceedings of the National Academy of Sciences 114 (38), E7997-E8006, 2017 | 448 | 2017 |
Update on melatonin receptors: IUPHAR Review 20 R Jockers, P Delagrange, ML Dubocovich, RP Markus, N Renault, ... British journal of pharmacology 173 (18), 2702-2725, 2016 | 445 | 2016 |
Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes A Bonnefond, N Clement, K Fawcett, L Yengo, E Vaillant, JL Guillaume, ... Nature genetics 44 (3), 297-301, 2012 | 414 | 2012 |
Oxytocin and vasopressin V1a and V2 receptors form constitutive homo-and heterodimers during biosynthesis S Terrillon, T Durroux, B Mouillac, A Breit, MA Ayoub, M Taulan, R Jockers, ... Molecular endocrinology 17 (4), 677-691, 2003 | 410 | 2003 |
The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization A Levoye, J Dam, MA Ayoub, JL Guillaume, C Couturier, P Delagrange, ... The EMBO journal 25 (13), 3012-3023, 2006 | 401 | 2006 |
Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy Transfer* 210 MA Ayoub, C Couturier, E Lucas-Meunier, S Angers, P Fossier, M Bouvier, ... Journal of Biological Chemistry 277 (24), 21522-21528, 2002 | 400 | 2002 |
Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? R Jockers, P Maurice, JA Boutin, P Delagrange British journal of pharmacology 154 (6), 1182-1195, 2008 | 395 | 2008 |
The use of resonance energy transfer in high-throughput screening: BRET versus FRET N Boute, R Jockers, T Issad Trends in pharmacological sciences 23 (8), 351-354, 2002 | 362 | 2002 |
Dual Signaling of Human Mel1a Melatonin Receptors via Gi2, Gi3, and Gq/11 Proteins L Brydon, F Roka, L Petit, P De Coppet, M Tissot, P Barrett, PJ Morgan, ... Molecular endocrinology 13 (12), 2025-2038, 1999 | 360 | 1999 |
The concise guide to pharmacology 2017/18: overview SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ... British journal of pharmacology 174, S1-S16, 2017 | 316 | 2017 |
Melatonin receptors: molecular pharmacology and signalling in the context of system bias E Cecon, A Oishi, R Jockers British journal of pharmacology 175 (16), 3263-3280, 2018 | 274 | 2018 |
Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers MA Ayoub, A Levoye, P Delagrange, R Jockers Molecular pharmacology 66 (2), 312-321, 2004 | 273 | 2004 |
Melatonin in type 2 diabetes mellitus and obesity A Karamitri, R Jockers Nature Reviews Endocrinology 15 (2), 105-125, 2019 | 268 | 2019 |
The BRET technology and its application to screening assays J Bacart, C Corbel, R Jockers, S Bach, C Couturier Biotechnology Journal: Healthcare Nutrition Technology 3 (3), 311-324, 2008 | 259 | 2008 |
Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease E Savaskan, MA Ayoub, R Ravid, D Angeloni, F Fraschini, F Meier, ... Journal of pineal research 38 (1), 10-16, 2005 | 259 | 2005 |
Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease YH Wu, JN Zhou, J Van Heerikhuize, R Jockers, DF Swaab Neurobiology of aging 28 (8), 1239-1247, 2007 | 256 | 2007 |